As respiratory season ramps up, we want to thank you for the vital role you play in providing high-quality, evidence-based care to Quartz members. This season is an important opportunity to revisit best practices in antibiotic prescribing for acute respiratory infections, particularly acute bronchitis and bronchiolitis.
Most cases of acute bronchitis and bronchiolitis are viral, yet antibiotics are still frequently prescribed. Unnecessary use not only exposes patients to avoidable side effects, but also drives antibiotic resistance, making future infections harder to treat. National guidelines from the CDC, IDSA, and AAP consistently recommend against antibiotics for uncomplicated cases in otherwise healthy patients. Effective alternatives exist — hydration, rest, fever reducers, and cough suppressants are usually sufficient to support recovery. When a bacterial infection is suspected, such as pneumonia, evaluation and targeted treatment remain essential.
Antibiotic stewardship protects patients today and preserves treatment effectiveness for tomorrow. While the HEDIS measure Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) reflects this priority, the goal goes far beyond measurement — it’s about ensuring the right care, at the right time, for better outcomes.
Best practice reminders:
- Acute bronchitis and bronchiolitis are usually viral and do not require antibiotics.
- Prescribe antibiotics only when bacterial infection is suspected based on clinical guidelines.
- Support patient understanding with clear communication on why antibiotics aren’t needed.
- Consider documenting education in the visit note or after visit summary.
For additional tools, guidelines, or assistance, you can connect with the Quartz Clinical Programs team at (877) 204-9577, Monday – Friday, 8 a.m. – 5 p.m.
